Posted in

Department News

Press release for Review authored by Brusko, Russ and Stabler

Join the University of Florida Diabetes Institute in the Centennial Celebration of Insulin’s Discovery 2021 marks the 100th year since Sir Frederick Banting, Charles Best, and Professor John Macleod from the University of Toronto reported the successful treatment of canine diabetes with a pancreas extract, now known as insulin. This…

Robert P. Seifert Among Forty High-Achieving Laboratory Professionals Honored by ASCP

ASCP’s 40 Under Forty Program Recognizes a New Generation of Laboratory Leaders JUNE 2021—Robert P. Seifert of the University of Florida, College of Medicine, Department of Pathology, Immunology and Laboratory Medicine, Gainesville, FL is among 40 high-achieving pathologists, pathology residents, and medical laboratory professionals under age 40 who have just…

WINNERS! – 3rd Annual Pathology Photo Contest

We had 379 votes this year in our photo contest! Way to spread the love of pathology! Congratulations to our top 3 winners.   #1. A Night Scene by Nada Al Qaysi #2. Eye Love Pathology by Nichole Allen #3. The Last Tree by Zhongbo Jin…

Congratulations to Dr. Iqbal Mahmud (Garrett lab)

Iqbal Mahmud Recognized for Publishing a Most Accessed Articles from Journal of the American Society for Mass Spectrometry Dr. Iqbal Muhmud’s paper Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives has been recognized as one of the most accessed papers of 2020 for the Journal of the American Society for Mass Spectrometry. Dr.

A ‘Rising Star’ Shines in Forbes

An assistant professor is named someone to watch in 2021 for her groundbreaking research on lupus. UF’s Erika Moore was recently named to Forbes magazine’s 30 Under 30 health care experts to watch in 2021. The 29-year-old Rhines Rising Star and Larry Hench endowed assistant professor of…

Congratulations to Dr. Weizhou Zhang on his newly funded Department of Defense, Breast Cancer Research Program, for the Office of the Congressionally Directed Medical Research Programs (CDMRP) award

The grant titled, ‘Developing a novel PROTAC-based NR4A1 degrader for breast-cancer therapy’ will focus on revolutionizing treatment regimens by replacing them with ones that are more effective, less toxic, and impact survival.  This is a partnering PI option with Dr. Zheng, Guangrong; co-investigators: Dr. Zhou, Daohong, Dr. Bacher, Rhonda and…